Premium
US-based healthcare firm Baxter International, which lost out to Chinese conglomerate Fosun International in its bid for Gland Pharma, is in talks to sell a part of its India portfolio, three persons familiar with the development told VCCircle. The firm has hired audit firm and management consultancy KPMG to find buyers ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
